FDA Adverse Event Injury Summary report: N

OGRE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 3641993 · Received February 5, 2014

Report

Report Number
2017233-2014-00047
Event Type
Injury
Date Received
February 5, 2014
Date of Event
March 27, 2013
Report Date
January 10, 2014
Manufacturer
W.L. GORE AND ASSOCAITES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE STATES: TYPE II ENDOLEAKS ARE DEFINED AS RETROGRADE FLOW THROUGH PATENT COLLATERAL VESSELS INTO THE PERIGRAFT SPACES (I.E., ANEURYSMAL SAC), WHICH HAVE BEEN EXCLUDED BY THORACIC OR ABDOMINAL ENDOGRAFT PLACEMENT. A TYPE II ENDOLEAK CAN ORIGINATE FROM ANY OF THE AORTIC BRANCH VESSELS, INCLUDING BUT NOT LIMITED TO; INTERCOSTAL, LEFT SUBCLAVIAN, PHARYNGEAL, LUMBAR, INFERIOR MESENTERIC, HYPOGASTRIC, SACRAL, GONADAL, OR ACCESSORY RENAL ARTERIES USER ARE MADE AWARE OF THE RISKS ASSOCIATED WITH TYPE II ENDOLEAKS IN THE IFU AND ARE INSTRUCTED TO CONSIDER THE RISKS AND BENEFITS DISCUSSED IN THE IFU FOR EACH PT BEFORE USING THE DEVICES.

Description of Event or Problem · 1

ON (B)(6) 2011, THIS PT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM MEASURING 60MM IN DIAMETER, AND WAS IMPLANTED WITH GORE EXCLUDER ENDOPROSTHESES, FEATURING THE C3 DELIVERY SYSTEM. THE PT TOLERATED THE PROCEDURE. ON (B)(6) 2013, THE PT UNDERWENT RE-INTERVENTION FOR A TYPE II ENDOLEAK. EMBOLIZATION WAS ATTEMPTED BUT WAS UNABLE TO BE PERFORMED DUE TO POOR ACCESS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
75118 OGRE EXCLUDER AAA ENDOPROSTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE AND ASSOCAITES NA

Patients

Seq Age Sex Outcome Treatment
1 83 YR Hospitalization| O| R